Teva Pharm to lay off a quarter of workforce, suspends dividend
December 14, 2017 at 07:28 AM EST
TEL AVIV (Reuters) - Teva Pharmaceutical Industries plans to reduce its workforce by 25 percent and suspend its dividend on ordinary shares in a much-anticipated overhaul to help pay back its massive debt.
